These findings strongly suggest the crosstalk between PRSS8 and Sphk1/S1PStat3 signaling, and opposite functions (i.e., tumor inhibition by PRSS8 and tumor promotion by Sphk1/S1P/Stat3 signaling). The gene discussed is PRSS8; the disease is neoplasm.